ubmslateCN-logo-ubm

CN Mobile Logo

Topics:

Podcasts

Podcasts

In this interview we discuss a recent study that identified genetic mechanisms of immunoresistance to treatment with anti-PD-1 antibodies.

In this interview we discuss the CheckMate 142 trial, which looked at nivolumab and ipilimumab for the treatment of metastatic colorectal cancer.

In this interview we discuss follow-up care and screening for second primary cancers in cancer survivors.

In this interview we discuss the management of late effects from radiotherapy in patients treated for gynecologic cancers.

In this interview we discuss the requirements for the effective implementation of a lung cancer screening program.

In this interview we discuss research and the treatment approaches for primary central nervous system lymphoma.

In this interview ahead of the 2016 ASCO Annual Meeting we discuss some of the prostate cancer trials to watch out.

Pages

Subscribe to Podcasts on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.